trial · primary record
Azacitidine
Acute Myeloid Leukemia, Adult
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 376 |
| Primary completion | 2030-04 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT07478991 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:33.570Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07478991
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- AZACITIDINE · approval
- Azacitidine · compound